1. Patient Navigation Effect on Cancer Patients' Quality of Life and Distress.
- Author
-
Bell, Jeffrey G., Secic, Michelle, Shaffer, Lynn E., Aldrich, Emily R., Schott, Valerie A., Taylor, Carolyn, Reynolds, Kelly, McMath, Tamara, and Elliott, John O.
- Subjects
TUMOR treatment ,CANCER patient psychology ,CLINICAL trials ,PSYCHOLOGICAL distress ,HEALTH status indicators ,LONGITUDINAL method ,QUALITY of life ,PATIENT-centered care ,EVALUATION of human services programs ,DESCRIPTIVE statistics ,ADULTS - Abstract
Background: Approximately one-half of adult cancer patients experience clinically significant psychological distress. Distress diminishes quality of life (QOL) and may interfere with patients' treatment compliance and outcomes. Objectives: To prospectively assess the effect of a navigation program on both distress and health-related QOL in a population of cancer patients. Methods: Cancer patients who had navigators were evaluated at enrollment and again at 3, 6, 12, and 18 months. At each time point patients were administered the National Comprehensive Cancer Network Distress Thermometer (DT) and the Functional Assessment of Cancer Therapy -- General (FACT-G). Results: Of 297 evaluable patients enrolled between February 2012 and February 2015, 71% received chemotherapy, 8% radiotherapy, and 13% hormonal therapy. DT scores, FACT-G total scores, subscales physical well-being, functional well-being, and emotional well-being all significantly improved from 6 to 18 months after enrollment. Both high and low users of the program had improved DT scores, total FACT-G scores, and various FACT-G subscale scores. Patients expressed high satisfaction with navigation. Discussion: This investigation found that distress and QOL improved over a period of 18 months while patients were in a navigation program after a diagnosis of cancer. DT and FACT-G scores improved whether patients were high or low users of the program. Lack of a control group makes definitive conclusions difficult. Conclusion: This navigation program may have positively impacted both distress and QOL in this cohort of cancer patients during and after treatment over a period longer than previously reported. [ABSTRACT FROM AUTHOR]
- Published
- 2020